IGENE BIOTECHNOLOGY INCIGENE BIOTECHNOLOGY INCIGENE BIOTECHNOLOGY INC

IGENE BIOTECHNOLOGY INC

No trades
See on Supercharts

IGNE fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

IGENE Biotechnology, Inc. engages in the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. It offers feed ingredients and nutraceutical products that includes astaxanthin. The company was founded by Robert Austin Milch and William T. Hall on October 27, 1981 and is headquartered in Columbia, MD.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

IGNE does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company